CYTOF · Altamira Therapeutics Ltd. · Debt
Market Cap
$514,392
Shares
5.72M
Volume · Oct 20
1600
Avg daily vol (3M)
5272
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current lease liabilities | 2025-06-30 | USD 145,852 | 6-K filed 2025-08-29 |
| Current portion of long-term borrowings | 2025-06-30 | USD 430,841 | 6-K filed 2025-08-29 |
| Noncurrent lease liabilities | 2025-06-30 | USD 198,762 | 6-K filed 2025-08-29 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.